Six months after Change Healthcare suffered its cyberattack, some health systems are still missing payments for patient encounters from February, according to a new report. It showed that small hospitals are still missing about 3-5% of expected net revenue for patient encounters from February.
Abarca executives see plenty of potential for new technologies but note the need to strike the right balance between tech and human intervention. Learn More.
Now's the perfect time to lock in your spot and start planning ahead. Secure your ticket today and enjoy peace of mind knowing you've already got a great deal.
Why wait? Grab your tickets and start getting ready for INVEST Digital Health on September 18, at Pegasus Park, Dallas!
Pharmacists and pharmacy technicians at a Walgreens store in Vancouver, Washington, have filed a petition to join the Pharmacy Guild. The workers argued that they are facing heavy workloads and inadequate staffing.
Livdelzi is now FDA-approved for treating the rare liver disease primary biliary cholangitis. Gilead Sciences added the drug to its pipeline via the $4.3 billion acquisition of CymaBay Therapeutics earlier this year.
Current trends are driven by various strategic and financial considerations from both established pharmaceutical companies and development-stage biotech firms. Understanding the valuation and accounting implications of these transactions are crucial for stakeholders to navigate the complex landscape effectively.
Next-generation robotic platforms have made a significant leap forward with real-time data analysis and intraoperative feedback, instilling a new confidence in surgical decisions while helping to minimize the potential for error during surgery.
In this episode, we stray from usual healthcare news to the realm of politics — Trump shooting, JD Vance's "childless cat lady" comment, gun rights and laws — though we still touch on mental health.
No comments